REPETTO, FEDERICA
REPETTO, FEDERICA
SCIENZE MEDICHE
Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa
2021-01-01 Repetto F.; Burzi L.; Ramondetta A.; Rozzo G.; Licciardello M.; Ribero S.; Quaglino P.; Dapavo P.
Cupping in herpes zoster infection
2022-01-01 Burzi, Lorenza; Repetto, Federica; Zenone, Mattia; Siliquini, Niccolò; Panzone, Michele; Ribero, Simone
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
2023-01-01 Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series
2022-01-01 Repetto, Federica; Burzi, Lorenza; Ribero, Simone; Quaglino, Pietro; Dapavo, Paolo
Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role?
2021-01-01 Burzi L.; Repetto F.; Ramondetta A.; Rozzo G.; Licciardello M.; Ribero S.; Quaglino P.; Dapavo P.
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs
2022-01-01 Burzi, Lorenza; Repetto, Federica; Ribero, Simone; Mastorino, Luca; Quaglino, Pietro; Dapavo, Paolo
Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab
2022-01-01 Parietti, Michele; Burzi, Lorenza; Ribero, Simone; Gallo, Giuseppe; Repetto, Federica; Dapavo, Paolo
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?
2022-01-01 Roccuzzo, Gabriele; Rozzo, Giulia; Burzi, Lorenza; Repetto, Federica; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa | 2021 | Repetto F.; Burzi L.; Ramondetta A.; Rozzo G.; Licciardello M.; Ribero S.; Quaglino P.; Dapavo P. | |
| Cupping in herpes zoster infection | 2022 | Burzi, Lorenza; Repetto, Federica; Zenone, Mattia; Siliquini, Niccolò; Panzone, Michele; Ribero, Simone | |
| Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study | 2023 | Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone | |
| Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series | 2022 | Repetto, Federica; Burzi, Lorenza; Ribero, Simone; Quaglino, Pietro; Dapavo, Paolo | |
| Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role? | 2021 | Burzi L.; Repetto F.; Ramondetta A.; Rozzo G.; Licciardello M.; Ribero S.; Quaglino P.; Dapavo P. | |
| Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs | 2022 | Burzi, Lorenza; Repetto, Federica; Ribero, Simone; Mastorino, Luca; Quaglino, Pietro; Dapavo, Paolo | |
| Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab | 2022 | Parietti, Michele; Burzi, Lorenza; Ribero, Simone; Gallo, Giuseppe; Repetto, Federica; Dapavo, Paolo | |
| Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness? | 2022 | Roccuzzo, Gabriele; Rozzo, Giulia; Burzi, Lorenza; Repetto, Federica; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro |